News

Drug Delivery Business6h
Insulet increases 2025 guidance on Q2 beats, 33% sales growth
Insulet (Nasdaq:PODD) shares ticked up before hours today on second-quarter results that came in ahead of the consensus ...
Drug Delivery Business21h
Tandem Diabetes Care posts Q2 sales beat, expects $1B in revenue for 2025
(Nasdaq:TNDM) shares fell after hours today on second-quarter results that topped the consensus sales forecast.
Drug Delivery Business20h
Senseonics posts Street-beating Q2 with 37% sales growth
Senseonics (NYSE:SENS) shares remained relatively unmoved today on second-quarter results that beat the consensus sales ...